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Abstract
Immunity to the murine cytomegalovirus (MCMV) is critically dependent on the innate response for initial containment of
viral replication, resolution of active infection, and proper induction of the adaptive phase of the anti-viral response. In
contrast to NK cells, the Va14 invariant natural killer T cell response to MCMV has not been examined. We found that Va14i
NK T cells become activated and produce significant levels of IFN-c, but do not proliferate or produce IL-4 following MCMV
infection. In vivo treatment with an anti-CD1d mAb and adoptive transfer of Va14i NK T cells into MCMV-infected CD1d
2/2
mice demonstrate that CD1d is dispensable for Va14i NK T cell activation. In contrast, both IFN-a/b and IL-12 are required
for optimal activation. Va14i NK T cell–derived IFN-c is partially dependent on IFN-a/b but highly dependent on IL-12. Va14i
NK T cells contribute to the immune response to MCMV and amplify NK cell–derived IFN-c. Importantly, mortality is
increased in CD1d
2/2 mice in response to high dose MCMV infection when compared to heterozygote littermate controls.
Collectively, these findings illustrate the plasticity of Va14i NK T cells that act as effector T cells during bacterial infection,
but have NK cell–like behavior during the innate immune response to MCMV infection.
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Introduction
The b-herpes murine cytomegalovirus (MCMV) is a well-
characterized model of viral infection that results in a non-
replicative, chronic infection of immune-competent animals [1].
MCMV is a cytopathic virus that is known to readily infect
peritoneal macrophages, dendritic cells (DC) and hepatocytes,
inducing significantpathologyinboth thespleen and the liver[2–5].
The acute response to this virus is dependent on natural killer (NK)
cell cytotoxicity and IFN-c production, as animals deficient in
perforin or IFN-c signaling rapidly succumb to infection [4,6–10].
The hepatic immune environment is greatly influenced by the
resident cellular subsets and has been shown to be primarily
tolerogenic [11,12]. The major hepatic lymphocyte population in
mice is a distinct family of T cells, Va14 invariant NK T (Va14i NK
T) cells [13,14]. Va14i NK T cells are innate lymphocytes that
display an effector memory phenotype, expressing CD69 and CD44
constitutively [15]. They are uniquely capable of rapidly producing
TH1a n dT H2 cytokines in response to antigenic stimulation [16].
The Va14i NK T cell repertoire is highly restricted, characterized by
aV a14-Ja18 rearrangement with an invariant junction preferentially
associatedwithVb8.2, Vb7, or Vb2 [17,18].Inresponse to the ligand
a-galactosylceramide (a-GalCer), Va14i NK T cells interactwith and
activate other immune cells including NK cells, CD8
+ Tc e l l s ,D C s ,
and macrophages [16]. This immune cell cross-talk is facilitated by
direct cell-cell contact and via cytokine release [19–22].
Much of the functional significance of Va14i NK T cell
activation in the context of viral infection has been provided by
activating the compartment prior to or concomitantly with viral
introduction in animal models [23–25]. Although this method
examines the potential contribution of activated Va14i NK T
cells, it does not examine the physiological function of these T cells
in response to viral infection without exogenous stimuli. In the
context of other microbial infections, the evidence for direct Va14i
NK T cell involvement is mixed, often being dependent on the
type of pathogen [26–32].
However, there is indirect evidence that Va14i NK T cells play
a role in anti-viral immune responses. A number of groups have
clearly shown that the expression of the antigen-presenting
molecule CD1d is often down-regulated by viruses in a myriad
of ways, including protein degradation, alterations in transcription,
or endosomal sequestration [33–35]. Va14i NK T cells have also
been shown to be preferential targets of infection and virus-
induced cell death [36,37]. This indicates that Va14i NK T cells
may have a potential role in the anti-viral response and it is
advantageous for the pathogen to prevent their activation.
To directly assess the role of Va14i NK T cells in the innate
anti-viral response, their activation status was examined following
MCMV infection in vivo. We found that Va14i NK T cells up-
regulate the high affinity IL-2 receptor-a, CD25, produce IFN-c,
but do not undergo proliferation. Importantly, we demonstrate
that CD1d is dispensable for Va14i NK T cell activation and
cytokine release in the context of MCMV. However, IFN-a/b and
IL-12 are both partially required for optimal activation of the
Va14i NK T cells in response to infection. We also show that in
the absence of a-GalCer treatment, Va14i NK T cells contribute
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derived IFN-c production. Collectively, our findings demonstrate
a role for the NK T cells in innate sensing of viral pathogens in an
unanticipated NK cell-like manner.
Materials and Methods
Mice
Inbred C57BL/6 and B6.SJL-Ptprca/BoAiTac mice were
purchased from Taconic Laboratory (Hudson, NY). B6.IL-
12p40
2/2 mice were purchased from the Jackson Laboratory
(Bar Harbor, ME). B6.CD1d
2/2 mice (a generous gift from Dr. L.
Van Kaer, Vanderbilt University, Nashville, TN) and B6.Ja18
2/2
mice (kindly provided by Dr. M. Taniguchi, Riken Research
Center for Allergy and Immunology, Yokohoma, Japan) were
bred, crossed to the B6 (.10 generations) to generate wild-type,
heterozygous, and knock-out littermates. Female IFN-a/bR1
2/2
mice originally generated on the 129.SvEv background and
backcrossed on to the C57BL/6 background were kindly provided
by Dr. M. Aguet [38] and bred in our facility. All mice, except B6
mice, were bred in pathogen-free breeding facilities at Brown
University (Providence, RI). All experiments were conducted in
accordance with institutional guidelines for animal care.
Virus & Infection Protocols
Stocks of Smith strain MCMV salivary gland extracts were
prepared as previously described [39]. Infections were initiated on
day 0 with 5610
4 plaque-forming units (PFU), administered via
i.p. injection. For survival studies, 3610
5 PFU were administered
via i.p. injection. For antibody-blocking experiments, mice
received blocking CD1d mAb (0.3 mg; clone 1B1; BD Pharmin-
gen) or rat IgG control Abs in PBS at the time of the infection.
Lymphocyte Isolation
To obtain splenic lymphocytes, spleens were minced, passed
through nylon mesh (Tetko, Kansas City, MO), washed once in
2% PBS-serum and cell suspensions were layered on Lympholyte-
M (Cedarlane Laboratories Ltd., Canada). Hepatic lymphocytes
were prepared by mincing and passage through a 70 mm nylon
cell strainer (Falcon, Franklin Lakes, NJ). After washing 3 times in
2% PBS-serum, cell suspensions were layered on a two-step
discontinuous Percoll gradient (Pharmacia Fine Chemicals, Piscat-
away, NJ). Splenocytes and hepatic lymphocytes were collected
after centrifugation for 20 min at 9006g.
Antibodies and Reagents
CD19-FITC, TCRb-FITC, CD11b-FITC, CD11c-FITC,
NK1.1-PE, CD1d-PE, B220-PerCP-Cy5, KLRG1-allophycocyanin,
CD25-APC, and TCRb-allophycocyanin were all purchased from
eBioScience (San Diego, CA). NK1.1-PerCp-Cy5.5, CD11b-PerCp,
CD4-PerCp, CD8-PerCp, CD11c-allophycocyanin, B220-allophy-
cocyanin, IFN-c-allophycocyanin and isotype control were pur-
chased from BD Pharmingen (San Diego, CA). For NK T cell
identification, CD1d tetramers were obtained from the National
Institute of Allergy and Infectious Disease MHC Tetramer Core
Facility at Emory University (Atlanta, GA). Additionally, the
following mAbs were purchased from BD Pharmingen and used
for ELISA: IFN-c mAbs (clone R4-6A2, and clone XMG1.2), IL-4
mAbs (clone 4B11 and BVD6-24G2), IL-2 mAbs (purified JES6-
N37-1A12 and biotinylated JES6-5H4) and streptavidin-peroxidase.
Adoptive Transfer of Enriched NK T Cells
Hepatic lymphocytes were isolated as described above from
congenic C57BL/6.SJL mice. For enrichment of hepatic NK T
cells, cells were first depleted of CD8
+, CD11c
+, CD11b
+, and
CD19
+ cells using the AutoMACS (Miltenyi Biotec) as instructed
by the manufacturer. 5–8610
6 cells were transferred via tail vein
injection into Ja18
2/2 or CD1d
2/2 mice. For NK T cell positive
selection hepatic lymphocytes were stained with anti-NK1.1 and
anti-CD5 mAbs or with anti-NK1.1 and CD1d tetramer and
sorted using a FACSAria (BD Biosciences). At the time of transfer
(1610
6 cells per mouse), mice were infected with 5610
4 pfu
MCMV. At 1.5 days post-infection, animals were sacrificed and
the donor population analyzed for IFN-c production.
Serum Cytokine Measurement
For all serum-based measurements, blood was collected via
cardiac puncture. Serum was separated from the cellular fraction by
centrifugation at 14,000 rpm at 4uC for 30 minutes. Serum levels of
cytokines were measured by ELISA or using the cytometric bead
array (CBA) mouse inflammation kit (BD Pharmingen).
Flow Cytometric Analysis
Following lymphocyte isolation, cells were suspended in PBS
containing 2% FCS. Cells were then incubated with 2.4G2 anti-Fc
receptor mAb and stained with indicated antibodies. Cells were
then fixed in 2% paraformaldehyde in PBS. Intracellular staining
for IFN-c protein was performed using the Cytofix/Cytoperm kit
(BD PharMingen). Depending on the experiment and the tissue,
2.5610
5–1610
6, events were collected on a FACSCalibur or
FACSAria. The data were analyzed using CellQuest software or
Diva software (Becton Dickinson, Franklin Lakes, NJ).
Statistical Analysis
Statistical significance, designated as a p-value #0.05, was
determined by paired, 2-tailed Student’s T-test.
Results
Va14i NK T cells are activated but do not proliferate in
response to MCMV infection in vivo
It is well documented that NK cells are necessary for the innate
anti-viral immune response to MCMV infection [6,40]. However,
Author Summary
An efficient immune response to viral infection requires
both innate and adaptive immune cells. Natural killer (NK)
cells are a critical innate cellular component of the immune
response to murine cytomegalovirus (MCMV). Natural killer
T (NK T) cells are non-classical T cells that have the
potential to bridge the two arms of the immune system.
However, the contribution of NK T cells to the anti-viral
immune response has not been extensively studied. In the
absence of additional stimuli, NK T cells actively participate
in the immune response to MCMV infection. Interestingly,
in contrast to their response to bacteria, we demonstrate
that only the innate NK T cell arm is activated during viral
infection while the adaptive branch, TCR engagement by
CD1d, is dispensable. NK T cells display signs of activation
in response to viral infection, increased expression of
CD25, a rapid decrease in cell number, and production of
the anti-viral cytokine IFN-c. The NK T cell response to
MCMV also influences the NK cell activity and the
inflammatory cytokine profiles. Understanding the physi-
ological function of these unique T cells in the context of
infection will aid in the development of novel therapeutic
and preventive treatments for viral infections.
NK T Cells Are Activated in Response to MCMV
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innate immune response. To address this issue, wild type B6 mice
were infected for 20–40 hrs and the activation status of Va14i NK
T cells was examined in the liver and spleen. In both tissues, Va14i
NK T cells display signs of activation, a decrease in NK T cell
numbers (Fig. 1A), and CD25 up-regulation by 20 hours post-
infection (Fig. 1B and data not shown).
CD1d dependent Ag recognition by Va14i NK T cells induces
their expansion [41]. Additionally, Va14i NK T cells have been
shown to proliferate in response to infection with LPS negative
Figure 1. Va14i NK T cells are activated but do not expand in response to MCMV infection in vivo. A, Splenic and hepatic leukocytes
were isolated from MCMV infected or vehicle treated mice at 20 and 40 hrs post-infection and the Va14i NK T cell compartment was analyzed by
staining with TCR-b and a-GalCer-loaded CD1d tetramer. B, Hepatic Va14i NK T cells were analyzed for the surface expression level of CD25 at 20 and
40 hrs p.i. compared to vehicle treated mice. C, The average expression level of CD25 on the surface of Va14i NK T cells, average MFI6SD is shown. D,
Hepatic leukocytes were isolated from MCMV infected or vehicle treated mice at the indicated days post-infection. The Va14i NK T cell compartment
was analyzed by staining with TCR-b and a-GalCer-loaded CD1d tetramer and the NK cell compartment was analyzed by gating on the NK1.1
+TCRb
2
cells. The percentage and absolute number of Va14i NK T and NK cells is shown. Results are representative of 3 to 5 independent experiments.
doi:10.1371/journal.ppat.1000106.g001
NK T Cells Are Activated in Response to MCMV
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Va14i NK T cell compartment does not expand in either number
or frequency (Fig. 1D), even at the peak of activation as assessed by
CD25 expression (Fig. 1C). We also performed an intra-cellular
staining for TCR at different days post MCMV infection. We
found that most of the cells were double positive for intracellular
and cell surface TCR, ruling out a possible lack of detection of the
Va14i NK T cells due to TCR internalization (data not shown). In
contrast to Va14i NK T cells, NK cells expand during MCMV
infection (Fig. 1D). Furthermore, the percentage of CD25
+ Va14i
NK T cells rapidly declines in comparison to the protracted
decrease in the percent of NK cells positive for the terminal
maturation marker, KLRG1 (data not shown).
Va14i NK T cells produce IFN-c in response to MCMV
infection
Va14i NK T cells produce IFN-c as early as 30 hours post-
infection (data not shown), peaking at day 1.5 post-infection
(Fig. 2A). At this time point, the frequency of IFN-c
+ Va14i NK T
cells is comparable to the frequency of IFN-c
+ NK cells in both
spleen and liver (Fig. 2B). In the spleen, despite a similar frequency,
the number of IFN-c
+ Va14i NK T cells is lower than the number
of IFN-c
+ NK cells. However, the number of IFN-c
+ Va14i NK T
cells is similar to the number of IFN-c
+ NK cell in the liver at day
1.5 post-infection (Fig. 2C). This indicates that these two subsets of
cells contribute equally to the overall amount of IFN-c in the liver.
Notably, Va14i NK T cells do not produce detectable amounts of
IL-4 during MCMV infection in either tissue (data not shown).
CD1d is dispensable for Va14i NK T cell activation in
response to MCMV infection
In order to investigate whether MCMV induced activation of
Va14i NK T cells requires CD1d, B6 mice were treated with a
blocking CD1d mAb or control antibody and infected with
MCMV. On day 1.5 post-infection, the percentage of hepatic
IFN-c
+ Va14i NK T cells in mice that received the anti-CD1d
mAb or control IgG was comparable (Fig. 3A). Similar results were
observed in the spleen (data not shown). To directly assess the
contribution of CD1d-mediated Ag presentation to MCMV-
induced activation and cytokine production from Va14i NK T
cells, adoptive transfer experiments were performed. Negatively
selected (purity .70%) or positively selected hepatic Va14i NK T
cells (purity .95%) from congenic wild-type B6.SJL mice were
adoptively transferred into CD1d
2/2 or Ja18
2/2 deficient hosts.
The recipient mice were simultaneously infected with MCMV for
1.5 days and the percentage of IFN-c
+ Va14i NK T cells was
determined. Regardless of the host expression of CD1d, donor
Va14i NK T cells produced similar amounts of IFN-c following
MCMV infection in vivo (Fig. 3B & 3C). Taken together, the
results indicate that CD1d is dispensable during MCMV induced
activation of Va14i NK T cells.
Va14i NK T cell IFN-c production in response to MCMV
infection is partially dependent on IFN-a/b and IL-12
High levels of IFN-a/band bioactive IL-12 characterize the innate
immune response to MCMV infection in vivo [43]. In the absence of
either cytokine, the innate anti-viral response is fatally impaired
[39,44].Here,MCMVinfectionofIFN-a/bR1
2/2andIL-12p40
2/2
mice further reveals that the activation of Va14i NK T cells at both 20
and 40 hours post-infection is independent of IL-12 and IFN-a/b,a s
assessed by the percentage of NK T cells (Fig. 4A & 4B) and CD25
expression (Fig. 4C). However, Va1 4 iN KTc e l l - d e r i v e dI F N - c is
highly dependent on IL-12 in the liver (Fig. 5) and spleen (data not
shown), similar to NK cells (Fig. 5). Notably, the Va14i NK T cell-
derived IFN-cresponse is reduced by ,50% in MCMV infected IFN-
a/bR1
2/2 mice, further mimicking NK cell dynamics (Fig. 5).
Va14i NK T cells amplify NK cell IFN-c production and
inflammatory cytokine production during MCMV
infection
Activated Va14i NK T cells interact with and activate other
immune cells such as NK cells, which subsequently produce
Figure 2. Va14i NK T cells produce IFN-c in response to MCMV
infection. A, Following surface staining, hepatic Va14i NK T cells and
NK cells were fixed, permeablized and stained for intracellular IFN-c. B,
The frequency and C, number of IFN-c
+ Va14i NK T and IFN-c
+ NK cells,
average6SD, is shown for infected B6 at day 1.5 post-infection. Results
shown are representative of 2 to 5 independent experiments.
doi:10.1371/journal.ppat.1000106.g002
NK T Cells Are Activated in Response to MCMV
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of Va14i NK T cell absence, we measured both NK cell-derived
IFN-c and serum inflammatory cytokines in infected NK T cell
deficient mice. The activation of NK cells in the spleen, as
determined by IFN-c production, was significantly reduced in
CD1d
2/2 mice when compared to heterozygous littermates
(Fig. 6A). Similarly, although not significant, a reproducible
reduction of NK cell IFN-c was also observed in MCMV infected
Ja18
2/2 mice compared to Ja18
2/+ littermates in five indepen-
dent experiments (Fig. 6A). Interestingly, an overall reduction of
the inflammatory cytokine profile (IL-12, IFN-c and TNF-a) was
seen in the blood of Ja18
2/2 animals in comparison to
heterozygous littermate controls at 1.5 days post-MCMV infection
in vivo (Fig. 6B). Likewise, inflammatory cytokines were
diminished in CD1d
2/2 mice compared to CD1d
+/2 littermates.
However, in the latter case, while IL-12 and TNF-a were
reproducibly decreased, only IFN-c was reduced significantly.
Notably, IL-4 and IL-10 were not detectable in the serum of
infected animals.
CD1d
2/2 mice but not Ja18
2/2 mice are more
susceptible to high dose MCMV infection than their
heterozygous littermates
To address whether Va14i NK T cells and/or CD1d
participate in the early control of MCMV infection, CD1d
2/2
and Ja18
2/2 animals, as well as littermate controls were used in
survival studies with high dose MCMV infection. CD1d
2/2 mice
were more susceptible than CD1d
+/2 mice, as only 50% of the
CD1d
2/2 mice lived beyond day 15. While Ja18
2/2 animals
were not more susceptible than their littermate, heterozygous
controls (Fig. 6), they were significantly more susceptible than
wild-type B6 mice from outside vendors (not shown). Taken
together, these results demonstrate that Va14i NK T cells
influence NK cell activity, the inflammatory cytokine profiles,
and that both Va14i NK T cells and other CD1d restricted T cells
are necessary for an optimal immune response to MCMV.
Discussion
The function of NK cells in anti-viral immunity has been
documented; however, evidence for a direct Va14i NK T cell role
has not been examined extensively. The results presented in this
report show that Va14i NK T cells sense MCMV infection in vivo,
without exogenous stimuli, such as a-GalCer. However, in
contrast to bacterial infection, we provide evidence that MCMV
induced Va14i NK T cell activation is TCR independent.
Va14i NK T cells can be activated directly by agonist
glycolipids presented by CD1d. For instance, a-GalCer immuni-
zation of B6 mice leads to IL-12 independent activation of Va14i
NK T cells [16]. In this case, Va14i NK T cells release copious
amount of IL-4 and IFN-c and subsequently proliferate. Gram-
negative LPS-negative a-proteobacteria, such as Sphingomonas,
Ehrlichia, Rickettsia, and Borrelia, express such agonist lipids and can
directly activate Va14i NK T cells [31,32,42,46]. Bacteria that do
not express agonist glycolipids have been reported to activate
Figure 3. CD1d is dispensable for Va14i NK T cell activation in
response to MCMV. A, B6 mice were injected with 300 mg of anti-
CD1d mAb or isotype control and infected with 5610
4 pfu/mouse
MCMV or vehicle control. Hepatic and splenic lymphocytes were
isolated from the host animals at day 1.5 post-infection and examined
for the percentage of IFN-c
+ Va14i NK T cells and IFN-c
+ NK cells. IFN-c
was not detectable in vehicle treated animals (data not shown). The
results are representative of 2 separate experiments. B,H e p a t i c
leukocytes were isolated from wild type, congenic B6 mice and
depleted of CD8
+, CD11b
+, CD19
+, and CD11c
+ cells to enrich for Va14i
NK T cells prior to injection via tail vein into CD1d
2/2 or Ja18
2/2 mice
infected with 5610
4 pfu/mouse MCMV or vehicle control. Hepatic and
splenic lymphocytes were isolated from the host animals at day 1.5
post-infection and examined for the percentage of IFN-c
+ Va14i NK T
cells. The results are representative of 4 separate experiments. C,
Hepatic leukocytes were isolated from wild type, congenic B6 mice and
CD5
+NK1.1
+cellsweresortedpriortoinjectionviatailveinintoCD1d
2/2
or Ja18
2/2 mice infected with 5610
4 pfu/mouse MCMV or vehicle
control. Hepatic and splenic lymphocytes were isolated from the host
animals at day 1.5 post-infection and examined for the percentage of
IFN-c
+ Va14i NK T cells. The results are representative of 3 independent
experiments.
doi:10.1371/journal.ppat.1000106.g003
NK T Cells Are Activated in Response to MCMV
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IL-12 production through recognition of endogenous lysosomal
glycosphingolipids, such as iGb3, presented by LPS-activated
dendritic cells [31,47]. Therefore, there are two major mecha-
nisms for the activation of Va14i NK T cells against bacteria
either via cognate Ag or via self-Ag with APC derived cytokines
[48]. Using MCMV infection in vivo, we now demonstrate a novel
activation pathway for Va14i NK T cells, mediated principally by
inflammatory cytokines.
MCMV induced activation of Va14i NK T cells clearly differs
from the two mechanisms described in response to bacterial
infection. First, as opposed to a-GalCer administration [41,49]
and a-proteobacteria infection [31], Va14i NK T cells do not
proliferate nor produce IL-4 following MCMV-induced activa-
tion. Second, while IL-12 is not required for optimal stimulation of
Va14i NK T cells in response to a-GalCer or sphingomonas-derived
glycolipids [20,42], here we show that Va14i NK T cell cytokine
production is impaired in IL-12 deficient animals in response to
MCMV infection. Finally, in vivo CD1d blocking experiments and
adoptive transfer of Va14i NK T cells into CD1d
2/2 mice
demonstrates that CD1d is dispensable for MCMV induced
activation of these lymphocytes. It should be noted that LPS-
induced Va14i NK T cell-derived IFN-c in vitro does not require
CD1d-mediated Ag presentation, instead exposure to IL-12 and
IL-18 is sufficient to activate these cells [50].
These data raise the question of why do bacteria such as
Salmonella typhimurium and Staphylococcus aureus activate Va14i NK T
cells in both an IL-12 and CD1d dependent manner, while
MCMV induced activation of Va14i NK T cells is CD1d
independent? There are several non-mutually exclusive possibil-
ities that could explain this apparent discrepancy. First, viruses
unlike bacteria, do not encode enzymatic machinery for lipid
synthesis. Second, the peak of the cytokine response to MCMV
occurs relatively early when compared to bacteria, allowing for
Figure 4. Va14i NK T cell activation in response to MCMV is independent of IFN-ab and IL-12. A and B, Hepatic leukocytes were isolated
from MCMV infected or vehicle treated B6, IL-12p40
2/2, and IFNa/bR1
2/2 mice at 20 and 40hrs post-infection and the Va14i NK T cell compartment
was analyzed by staining with TCR-b and a-GalCer-loaded CD1d tetramer. The percentage of Va14i NK T cells in the liver of B6, IL-12p40
2/2, and
IFNa/bR1
2/2 mice, uninfected and at indicated time points post-infection is shown in B as average6SD. C, Hepatic Va14i NK T cells were analyzed for
the surface expression of CD25 at 20 and 40 hrs p.i. compared to vehicle treated B6, IL-12p40
2/2, and IFNa/bR1
2/2 mice. The MFI of CD25 expression
on the Va14i NK T cells is shown as average6SD. Results shown are representative of 2 to 5 independent experiments.
doi:10.1371/journal.ppat.1000106.g004
NK T Cells Are Activated in Response to MCMV
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driven self-Ag activation. Third, while Gram negative bacteria
cytokine-driven self-Ag activation of Va14i NK T cells was
demonstrated in vitro using bone marrow derived DCs [31,47], it
has been recently demonstrated that plasmacytoid dendritic cells
(pDCs) are the quasi-exclusive source of IFN-a/b, IL-12 and
TNF-a early during MCMV infection [51]. It is therefore possible
that depending on the pathogen and the source and/or phenotype
of recruited CD1d
+ DCs may lead to differential activation of
Va14i NK T cells.
pDCs and dendritic cells recognize MCMV through TLR9, an
essential component of the innate immune defense against
Figure 5. Optimal Va14i NK T cell IFN-c response requires IFN-a/b and IL-12. A, Hepatic leukocytes isolated from B6, IL-12p40
2/2, and IFNa/
bR1
2/2 mice at 40 hrs p.i. were stained with a-GalCer CD1d tetramer, TCRb, and NK1.1 followed by permeabilization and stained for intracellular IFN-c
and compared to vehicle treated mice. IFN-c
+ Va14i NK T cells and NK cells are shown. B, The percent of IFN-c
+ Va14i NK T cells and NK cells,
average6SD, is shown for infected B6, IL-12p40
2/2, and IFNa/bR1
2/2 mice. IFN-c was not detectable in vehicle treated animals (data not shown).
Results shown are representative of 2 to 5 independent experiments.
doi:10.1371/journal.ppat.1000106.g005
NK T Cells Are Activated in Response to MCMV
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response to MCMV is impaired in TLR9
2/2 mice [52].
Interestingly, the serum level of both IFN-a and IL-12 is reduced
in TLR9
2/2 mice following MCMV infection [52,53], supporting
our findings that the absence of these cytokines impairs the Va14i
NK T cell response to MCMV. However, activation of Va14i NK
T cells by TLR9-stimulated dendritic cells was recently shown to
be CD1d dependent [54]. The latter study was performed in vitro
using BMDCs grown for 14 days prior to being pulsed with CpG
for 16 hours. This procedure clearly differs from MCMV infection
in vivo where the peak of the Va14i NK T cell response is at 1.5
days post-infection. It is possible that some pathogen-derived
products such as CpG may increase endogenous glycolipid
presentation during the anti-viral response but that this process
is not yet initiated at the peak of the innate response to MCMV.
In the context of MCMV infection, we failed to detect an
expansion of the Va14i NK T cells. Instead, there is a gradual loss
of these cells in the liver and spleen following infection.
Figure 6. The innate immune cytokine response is impaired in the absence of Va14i NK T cells. A, Splenic leukocytes were isolated from
uninfected or MCMV infected CD1d
2/2 and CD1d
+/2 littermates or Ja18
2/2 and Ja18
+/2 littermates at 1.5 days post-infection and analyzed for
intracellular IFN-c. The percentage of IFN-c
+ NK cells is shown. The results are representative of 5 independent experiments (*, P,0.05). B, Serum
levels of cytokines were measured by ELISA or using the cytometric bead array inflammation kit at 1.5 days post-infection (*, P,0.05). The results are
representative of 3 independent experiments. C, Percent survival following high dose MCMV infection.
doi:10.1371/journal.ppat.1000106.g006
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MCMV infection promotes the activation of Va14i NK T cells
that release cytokines but do not proliferate and subsequently die.
It is also possible that Va14i NK T cells preferentially undergo
virus-induced apoptosis similarly to what has been reported during
the anti-viral response against lymphocytic choriomeningitis virus
infection in vivo [36].
The early immune response to MCMV is characterized by the
production of high levels of inflammatory cytokines [51,55]. Type
I IFNs, which are critical for anti-viral immunity, can be detected
very early following MCMV infection and mediate the prolifer-
ation and survival of activated lymphocytes [56]. Additionally, the
classical TH1-promoting cytokine, IL-12, is also produced early
and is necessary for NK cell-derived IFN-c [57]. Infection of mice
deficient in either IFN-a/b signaling or bioactive IL-12 clearly
demonstrates that neither cytokine alone is sufficient to mediate an
optimal IFN-c response from Va14i NK T cells in response to
MCMV. IFN-a/b is thought to negatively regulate the production
of IFN-c via inhibition of IL-12 thus ensuring that IFN-c does not
prematurely inhibit proliferation [58]. The timing of IL-12
production may be critical for Va14i NK T cells as MCMV
infected IFN-a/bR1
2/2 mice produce high levels of IL-12 [56],
yet we show that Va14i NK T cell-derived IFN-c is impaired in
IFN-a/bR1
2/2 mice. It is also currently unclear if IFN-a/b acts
directly on this innate T cell population in the context of MCMV
infection. These issues warrant further inquiry.
Va14i NK T cells are widely appreciated for their rapid
cytokine production and ability to interact with and activate both
innate and adaptive immune cells [15]. The cross-talk between
Va14i NK T cells and NK cells in the context of a-GalCer-
mediated stimulation requires IFN-c and IL-12 production to
promote optimal NK cell activation [19,20]. Va14i NK T cell-
mediated activation of NK cells has been shown to be required for
anti-tumor immunity [59,60] but not for viral infection. We show
that in the absence of the Va14i NK T cell population, the NK
cell response to MCMV in vivo is impaired. Notably, Va14i NK T
cells also mediate activation and maturation of DCs and
macrophages [61,62], cells critical for the induction of the anti-
viral immune response via production of high levels of key
inflammatory cytokines such as IFN-a/b and IL-12 [62]. We are
currently investigating the possibility that the function of these
subsets in response to MCMV infection may also be altered in the
absence of Va14i NK T cells.
Our data suggest that Va14i NK T cells contribute to the
overall immune response to MCMV. However, it has been shown
that at a low infecting dose, Ja18
2/2 mice and B6 wild-type
control animals have equivalent viral titers [25]. Using Va14i NK
T cell deficient mice and littermate controls, we examined the
pathological impact of Va14i NK T cell absence during high dose
MCMV challenge. While both Ja18
2/2 and CD1d
2/2 animals
are more susceptible than wild-type B6 mice from outside vendors,
only CD1d
2/2 mice are less resistant than heterozygous littermate
control mice to high dose MCMV infection. This suggests that
Va14i NK T cells as well as other CD1d restricted T cells are
required for an optimal immune response to MCMV.
Collectively, the findings presented in this report indicate that
Va14i NK T cells actively participate in the innate immune
response to MCMV in vivo and directly impact the quality of the
immune response. However, the mechanism of their activation
differs from bacterial induced activation and in this case, NK T
cell functions mirror NK cell functions. These data define a
previously unappreciated role for CD1d restricted T cells in anti-
viral immunity and provide additional insight into the affect of
innate immune manipulation on the overall outcome of an
immune response.
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